Theralymph : An innovative therapy for lymphedema
OUR MAIN OBJECTIVES
Describe the physiopathology of lymphedema to better understand mechanisms of loss of lymphatic function.
Identify therapeutic targets for lymphedema to restore the lymphatic flow.
Validate therapeutic targets in preclinic models of lymphedema.
Perform a Phase I/IIa gene therapy clinical trial on patients who developed lymphedema after breast cancer using lentiflash vectors.
GIGA-Cancer, LBTD, University of Liege, Belgium A 2-years post-doctoral position is available now in the Agnès Noel’s lab group (starting in January 2023 or Spring 2023) at the GIGA-Cancer to work in the context of the TheraLymph Horizon 2020...
Post-doctoral position at I2MC-Toulouse (France) : Theralymph : An innovative therapy for lymphedema A postdoctoral position, with salary funded for three years is available in the team “Molecular regulations of (lymph)angiogenic growth factors in vascular diseases”...